DE3879873D1 - Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. - Google Patents

Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
DE3879873D1
DE3879873D1 DE8888810760T DE3879873T DE3879873D1 DE 3879873 D1 DE3879873 D1 DE 3879873D1 DE 8888810760 T DE8888810760 T DE 8888810760T DE 3879873 T DE3879873 T DE 3879873T DE 3879873 D1 DE3879873 D1 DE 3879873D1
Authority
DE
Germany
Prior art keywords
physiologically active
active substances
production
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888810760T
Other languages
English (en)
Other versions
DE3879873T2 (de
Inventor
Jin-Emon C O Inst Of B Konishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Publication of DE3879873D1 publication Critical patent/DE3879873D1/de
Application granted granted Critical
Publication of DE3879873T2 publication Critical patent/DE3879873T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8888810760T 1987-11-06 1988-11-07 Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. Expired - Fee Related DE3879873T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28176487 1987-11-06

Publications (2)

Publication Number Publication Date
DE3879873D1 true DE3879873D1 (de) 1993-05-06
DE3879873T2 DE3879873T2 (de) 1993-08-05

Family

ID=17643645

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888810760T Expired - Fee Related DE3879873T2 (de) 1987-11-06 1988-11-07 Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Country Status (5)

Country Link
US (1) US4985254A (de)
EP (1) EP0315591B1 (de)
AT (1) ATE87484T1 (de)
DE (1) DE3879873T2 (de)
ES (1) ES2061727T3 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE94401T1 (de) * 1988-04-30 1993-10-15 Nippon Zoki Pharmaceutical Co Physiologisch wirkende substanzen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen davon.
JP2588109B2 (ja) * 1993-03-19 1997-03-05 日本臓器製薬株式会社 鎮痛剤
JP3213831B2 (ja) * 1993-08-06 2001-10-02 日本臓器製薬株式会社 被検物質の活性測定方法
JP3213832B2 (ja) * 1993-08-06 2001-10-02 日本臓器製薬株式会社 被検物質の活性測定法
JP2594222B2 (ja) * 1993-09-28 1997-03-26 日本臓器製薬株式会社 新規生理活性物質−ｋｆ
AU721804B2 (en) * 1997-01-08 2000-07-13 Nippon Zoki Pharmaceutical Co., Ltd. Nitrogen monoxide production suppressor
JP4033936B2 (ja) * 1997-01-08 2008-01-16 日本臓器製薬株式会社 一酸化窒素産生抑制剤
JPH1180005A (ja) * 1997-09-12 1999-03-23 Nippon Zoki Pharmaceut Co Ltd 骨粗鬆症治療剤
KR19990044835A (ko) 1997-11-28 1999-06-25 고니시 진우에몬 생약추출물
AU2402399A (en) * 1998-04-27 2000-11-02 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for ischemic diseases
KR20010020741A (ko) 1999-04-15 2001-03-15 고니시 진우에몬 신규의 생체 활성화 물질
CN1312080A (zh) 2000-02-18 2001-09-12 日本脏器制药株式会社 含有脂肪酸的组合物
US6913900B2 (en) * 2001-08-29 2005-07-05 Nippon Zoki Pharmaceutical Co., Ltd. Plasma prekallikrein activation and kallikrein production assay
CN1207005C (zh) * 2002-10-31 2005-06-22 威世药业（如皋）有限公司 含生物活性物质的兔皮和其用途
KR101307999B1 (ko) 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
US20060134646A1 (en) * 2004-12-17 2006-06-22 Ansari Aftab A Method for treatment of HIV infection
WO2007090081A2 (en) * 2006-01-27 2007-08-09 The Board Of Governors For Higher Education State Of Rhode Island And Providence Plantations Analysis of mycophenolic acid in saliva using liquid chromatography tandem mass spectrometry
CN101732348B (zh) * 2008-11-11 2015-01-14 威世药业（如皋）有限公司 牛痘疫苗致炎兔皮提取物在制备急性脑血管疾病治疗药物中的用途
TWI483729B (zh) 2010-03-11 2015-05-11 Nippon Zoki Pharmaceutical Co 慢性前列腺炎、間質性膀胱炎及／或排尿障礙之改善或治療劑
AU2011316756B2 (en) 2010-10-14 2015-01-22 Nippon Zoki Pharmaceutical Co., Ltd A method for promoting the synthesis of collagen and proteoglycan in chondrocytes
CN105163746A (zh) 2013-04-30 2015-12-16 日本脏器制药株式会社 提取物和含有该提取物的制剂
JP6820831B2 (ja) 2014-08-08 2021-01-27 日本臓器製薬株式会社 肝の保護方法及び肝保護剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5835117A (ja) * 1981-08-25 1983-03-01 Nippon Zoki Pharmaceut Co Ltd 新規生理活性物質ｎｓｈ
JP2651674B2 (ja) * 1987-07-23 1997-09-10 日本臓器製薬 株式会社 新規生理活性物質及びその製造方法
FR2649273B1 (fr) * 1989-06-30 1991-09-13 Portenseigne Radiotechnique Dispositif d'egalisation autoadaptative pour des echantillons numeriques codes en duobinaire
JP3469377B2 (ja) * 1995-10-25 2003-11-25 信越化学工業株式会社 塩化ビニル系重合体の製造方法

Also Published As

Publication number Publication date
ES2061727T3 (es) 1994-12-16
ATE87484T1 (de) 1993-04-15
EP0315591A3 (en) 1990-05-16
US4985254A (en) 1991-01-15
EP0315591A2 (de) 1989-05-10
DE3879873T2 (de) 1993-08-05
EP0315591B1 (de) 1993-03-31

Similar Documents

Publication Publication Date Title
DE3879873D1 (de) Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3876877D1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE69713526D1 (de) Lösliche prodrugs von paclitaxel
IT1241996B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
DE69127470T2 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
ES2045182T3 (es) Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.
ATE283047T1 (de) Verwendung von ibudilast zur herstellung eines arzneimittels zur behandlung multiple sklerose
ES2073425T3 (es) Una nueva glicoproteina de tipo trombomodulina susceptible de ser obtenida a partir de la orina.
UA45942A (uk) 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція
ATE20309T1 (de) Pharmazeutische zubereitung.
ATE123944T1 (de) Verwendung von trifluormethylphenyl- tetrahydropyridinen zur herstellung von arzneimitteln zur behandlung anxio-depressiver erkrankungen.
ATE94401T1 (de) Physiologisch wirkende substanzen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen davon.
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
DE3682811D1 (de) Pharmazeutische zusammensetzung zur heilung und verhuetung kardiovaskularer krankheiten und verfahren zu ihrer herstellung.
NO870560D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
DK83889D0 (da) Anvendelse af laegemiddel til hindring af intraventrikulaer bloedning hos for tidligt foedte boern
DE69621786T2 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
KR890012942A (ko) 5-치환된 오르니틴 유도체
DE69011857D1 (de) Verwendung von GnRH-analog zur Herstellung eines Arzneimittels zur Behandlung von Motilitätsstörungen.
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
DK601788D0 (da) Anvendelse af antibiotikaene ll-e19020alfa og ll-e19020beta til behandling af visse fjerkraesygdomme
ATE53384T1 (de) 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee